Kuwayama et al. (2005), Japan
|
NM
|
Prospective
|
Embryo
|
88 embryos
|
227 embryos
|
CsR; CPR; LBR
|
None declared
|
Moderate risk
|
Chen et al. (2013), China
|
2010.04–2012.05
|
Retrospective
|
Embryo
|
226 cycles; 308 embryos
|
106 cycles; 150 embryos
|
CsR; IR; CaR; CPR; OPR; MR; LBR; BB; MR
|
Yes
|
Low risk
|
Panagiotidis et al. (2013), Greece
|
2009.06–2011.09
|
Prospective
|
Embryo
|
224 cycles; 513 embryos
|
208 cycles; 492 embryos
|
CsR; PβR; IR; CaR; CPR; OPR; MR; LBR; BB; MR
|
None declared
|
Low risk
|
Desai et al. (2013), America
|
2011.01–2012.08
|
Retrospective
|
Embryo
|
95 cycles; 184 embryos
|
161 cycles; 302 embryos
|
CsR; IR; CaR; CPR; OPR; MR; LBR; BB; MR
|
None declared
|
Low risk
|
Hashimoto et al. (2013), Japan
|
2011.07–2012.09
|
Prospective
|
Embryo
|
100 embryos
|
163 embryos
|
CsR; IR; OPR
|
Yes
|
Moderate risk
|
Roy et al., Australia (2014)
|
NM
|
Prospective
|
Embryo
|
23 embryos
|
13 embryos
|
CsR; OPR
|
Yes
|
Serious risk
|
Iwahata et al. (2015), Japan
|
2011.11–2013.12
|
Retrospective
|
Embryo
|
302 cycles; 313 embryos
|
539 cycles; 561 embryos
|
CsR; IR; CPR; MR; LBR; MR
|
None declared
|
Low risk
|
Paffoni et al. (2011), Italy
|
2007.06–2009.04
|
Retrospective
|
Oocyte/embryo
|
51 cycles; 261 MII oocytes/87 embryos
|
53 cycles; 268 MII oocytes/116 embryos
|
CsR; IR; FR; ClR; GQER; CPR; LBR
|
None declared
|
Low risk
|
Papatheodorou et al. (2013), Greece
|
2007.02–2010.12
|
Prospective
|
Oocyte
|
598 MII oocytes
|
608 MII oocytes
|
CsR; FR; ClR; GQER; PβR; IR; CPR; MR; OPR; LBR
|
None declared
|
Low risk
|
De Munck et al. (2016), Belgium
|
2014.01–2015.07
|
Prospective
|
Oocyte/embryo
|
253 MII oocytes
|
257 MII oocytes
|
CsR; FR; GQER; PβR; MR; OPR
|
No funding
|
Low risk
|
Gook et al. (2016), Australia
|
2012.06–2015.06
|
Prospective
|
Oocyte
|
39 MII oocytes
|
79 MII oocytes
|
CsR
|
None declared
|
Serious risk
|
Sarandi et al. (2016), France
|
2014.11–2015.05
|
Prospective
|
Oocyte
|
96 GV/MI oocytes
|
118 GV/MI oocytes
|
CsR
|
None declared
|
Serious risk
|